Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by Sqidmandonon Oct 16, 2020 11:20am
197 Views
Post# 31728296

I don’t think we are grasping the gravity of situation

I don’t think we are grasping the gravity of situationAll

at this point, I am thoroughly depressed and disgusted at the same time. As a long time investor with a significant position in my portfolio, I cannot believe how bad the management team and IR person have handled this. I know I shouldn't be surprised - this is a small company, and the level of execs is not top notch. And whileSPCEO and WINO both pointed out that Paul's performance was less than stellar, they are too nice - it was a disaster, an abject failure, of one of his most important jobs, which is to be the leader, the front man, cheerleader, confidence-instiller, spin doctor, vision-caster....he HAS TO be able to answer the most straight-forward question clearly and confidently - HAS TO. How is everyone on this board able to do it, and Paul is not? I am not trying to re-state the problem, but we need an advocate for our position. The folks here own a very very large portion of the company. It's because we won't sell that we keep getting beat up by manipulators and short sellers. I know SPCEO has access, but he is a friendly investor, and the stock has done well by him. You need both the gentle hand, and the "bad cop", and I don't think we have that. I don't own enough for them to care about me - but someone who does please please write a stern note to Paul and tell him in no uncertain terms that his performance was completely unacceptable, and that it won't be tolerated in the future. Tell Paul, tell the bod...They need to know that if things don't change there will be consequences. I'm begging...
Bullboard Posts